NicOx, the French drugmaker developing treatments with Pfizer, slipped to its lowest level in 29 months in Paris trading after saying the U.S. company won't develop an experimental glaucoma medicine in Asia.
More
More
Showing posts with label nicox. Show all posts
Showing posts with label nicox. Show all posts
Monday, August 25, 2008
Tuesday, May 06, 2008
NicOx - clinical trials, ain't they a bitch
Pfizer has decided not to take NicOx's experimental glaucoma drug PF-03187207 into final Phase III tests after a mid-stage study failed to met its primary endpoint, sending NicOx shares tumbling.
The news is a major blow for NicOx, which has been working on developing eye treatments with Pfizer for four years, and shares in the French biotechnology company dived 30 percent to 10.10 euros by 3:20 a.m. EDT (0720 GMT) on Tuesday.
More
The news is a major blow for NicOx, which has been working on developing eye treatments with Pfizer for four years, and shares in the French biotechnology company dived 30 percent to 10.10 euros by 3:20 a.m. EDT (0720 GMT) on Tuesday.
More
Subscribe to:
Posts (Atom)